Related Experiment Video
Updated: Jun 24, 2026
07:09
Assessment of Pulmonary Capillary Blood Volume, Membrane Diffusing Capacity, and Intrapulmonary Arteriovenous Anastomoses During Exercise
Published on: February 20, 2017
Venous admixture in COPD: pathophysiology and therapeutic approaches
Christopher B Cooper1, Bartolome Celli
1David Geffen School of Medicine, University of California, Los Angeles, California 90095-1690, USA. ccooper@mednet.ucla.edu
COPD
|April 9, 2009
Summary
Patients with chronic lung disease and hypoxemia may benefit from an arterio-venous fistula. This novel approach could increase oxygen levels and improve exercise performance in conditions like COPD.
Area of Science:
- Pulmonary Medicine
- Respiratory Physiology
Background:
- Chronic lung diseases like COPD impair gas exchange, causing ventilation-perfusion (V/Q) mismatch.
- Low V/Q leads to venous admixture and hypoxemia, often refractory to oxygen therapy, especially during exercise.
Purpose of the Study:
- To explore therapeutic strategies for hypoxemia in chronic lung diseases.
- To investigate methods for increasing mixed venous oxygen content to counteract venous admixture.
Main Methods:
- Discussion of the mechanisms of hypoxemia due to venous admixture.
- Exploration of interventions to increase mixed venous oxygen content.
- Consideration of therapeutic arterio-venous fistula creation as a potential treatment.
Main Results:
- Venous admixture significantly contributes to hypoxemia and reduced tissue oxygen delivery.
- Increasing mixed venous oxygen content is a theoretical approach to ameliorate these effects.
- Therapeutic arterio-venous fistula creation presents a novel, minimally invasive option.
Conclusions:
- Arterio-venous fistula creation warrants further investigation for treating hypoxemia in COPD and other chronic lung diseases.
- This intervention could improve exercise performance in patients with chronic hypoxemia.
- A favorable risk-benefit profile is anticipated for this approach.
Related Concept Videos
01:20COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:29Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment